Adam M. Veness

SVP, GENERAL COUNSEL AND SEC. · DIANTHUS THERAPEUTICS, INC. /DE/ · CIK 0001778623

FILING MIX · LIFETIME63%/37%

BUYS

SELLS

TOTAL VALUE

$2.96M

COMPANIES

ACTIVE SINCE

Jan 2024

HOLDINGS NOW

AVG SELL PX

$80.80

Trades · vs SPY

Loading price series…

Performance · forward returns vs SPY

No backtest data available for Adam M. Veness. Backtests are computed for purchase (P) and sale (S) transactions with resolvable price history.

Holdings over time

DNTH · 0 shares · as of Jun 17, 2026

Trading cadence · quarterly flow

BUY ● SELL ●

2024

2025

2026

FLOW · 5 buys / 3 sellsCOVERAGE · 10 quarters

Form 4 filings · all activity

COMPANY	TYPE	SHARES	PRICE	VALUE	HELD AFTER	TRADE DATE	FILED	DETAILS
DNTH DIANTHUS THERAPEUTICS, INC. /DE/	SALE10b5-1 10b5-1 plan	13,229	$81.38	$1.08M	0	Jun 17, 2026	Jun 18, 2026 ↗	View →
DNTH DIANTHUS THERAPEUTICS, INC. /DE/	SALE10b5-1 10b5-1 plan	16,771	$80.34	$1.35M	13,229	Jun 17, 2026	Jun 18, 2026 ↗	View →
DNTH DIANTHUS THERAPEUTICS, INC. /DE/	PURCHASE SVP, General Counsel and Sec.	30,000	$17.88	$536.4K	30,000	Jun 17, 2026	Jun 18, 2026 ↗	View →
DNTH DIANTHUS THERAPEUTICS, INC. /DE/	SALE SVP, General Counsel and Sec.	30,000	—	—	80,000	Jun 17, 2026	Jun 18, 2026 ↗	View →
DNTH DIANTHUS THERAPEUTICS, INC. /DE/	PURCHASEGRANT Stock grant	100,000	—	—	100,000	Feb 3, 2026	Feb 4, 2026 ↗	View →
DNTH DIANTHUS THERAPEUTICS, INC. /DE/	PURCHASEGRANT Stock grant	100,000	—	—	100,000	Feb 3, 2025	Feb 4, 2025 ↗	View →
DNTH DIANTHUS THERAPEUTICS, INC. /DE/	PURCHASEGRANT Stock grant	75,000	—	—	75,000	May 23, 2024	May 28, 2024 ↗	View →
DNTH DIANTHUS THERAPEUTICS, INC. /DE/	PURCHASEGRANT Stock grant	110,000	—	—	110,000	Jan 24, 2024	Jan 26, 2024 ↗	View →

Other insiders · DNTH

Loading peer insiders…

About this filer

CIK 0001778623

ROLE

SVP, General Counsel and Sec.

PRIMARY

DNTH

COMPANIES

ACTIVE SINCE

Jan 2024

MARKETPEEL · /INSIDER/0001778623DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE

The morning brief, before the bell.